API SUPPLIERS

API Suppliers

53

US DMFs Filed

34

CEP/COS Certifications

2

JDMFs Filed

10

Other Certificates

0

Other Suppliers

10

API REF. PRICE (USD / KG)

59

API Market Place

25

INTERMEDIATES

0

DOSSIERS // FDF

USA (Orange Book)

Europe

Canada

Australia

South Africa

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

EXCIPIENTS

231

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

2

USFDA Exclusivities

1

DIGITAL CONTENT

Blog #PharmaFlow

1

News

23

REF STANDARD

EDQM

3

USP

0

JP

0

Other Listed Suppliers

5

SERVICES

0

Full Screen View

Cosette Pharma

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Cosette Pharmaceuticals Announces the Approval and Launch of First Generic Version of RECTIV® (nitroglycerin) Ointment, 0.4%, with 180 Days Competitive...

Details:

Rectiv-Generic (nitroglycerin) is a nitrate vasodilator which activates guanylate cyclase, resulting in an increase of cyclic GMP in smooth muscle and other tissues. It is indicated for the treatment of moderate to severe pain associated with chronic anal fissure.

Lead Product(s): Nitroglycerin

Therapeutic Area: Gastroenterology Product Name: Rectiv-Generic

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable February 22, 2024

ASK
US

Upload
your Marketing & Sales content

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Find Drugs in Development News & Deals for Nitroglycerin

Nitroglycerin

Nitroglycerin

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

53 API Suppliers

34 USDMF

2 CEP/COS

10 JDMF

1 KDMF

5 NDC API

10 Listed Suppliers

DEVELOPMENTS

1 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

DOSSIERs // Finished Dosage Formulations

296 Dossiers

102 FDA Orange Book

121 Europe

20 Canada

10 Australia

4 South Africa

39 Listed Dossiers

DRUG PRODUCT COMPOSITION

SPRAY, METERED;SUBLINGUAL - 0.4MG/SPRAY

FILM, EXTENDED RELEASE;TRANSDERMAL - 0.1MG/HR

FILM, EXTENDED RELEASE;TRANSDERMAL - 0.2MG/HR

FILM, EXTENDED RELEASE;TRANSDERMAL - 0.3MG/HR

FILM, EXTENDED RELEASE;TRANSDERMAL - 0.4MG/HR

FILM, EXTENDED RELEASE;TRANSDERMAL - 0.6MG/HR

FILM, EXTENDED RELEASE;TRANSDERMAL - 0.8MG/HR

POWDER;SUBLINGUAL - 0.4MG/PACKET

TABLET;SUBLINGUAL - 0.3MG

TABLET;SUBLINGUAL - 0.4MG

TABLET;SUBLINGUAL - 0.6MG

OINTMENT;INTRA-ANAL - 0.4%

AEROSOL, METERED;SUBLINGUAL - 0.4MG/SPRAY

OINTMENT;TRANSDERMAL - 2%

RELATED EXCIPIENT COMPANIES

Suppliers

31 Roquette

29 Kerry

18 Microlex e.U

18 SPI Pharma

14 BASF

11 Sigachi Industries

11 Gangwal Healthcare

8 Beneo

7 Gangwal Chemicals

6 Corel Pharma Chem

6 DFE Pharma

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

6 Actylis

6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

4 Nanjing Well Pharmaceutical

4 Vasa Pharmachem

4 ACG Worldwide

4 Ingredion Pharma Solutions

4 DKSH

4 Rochem International Inc

3 Lonza Capsugel

3 Doshion Polyscience

3 Pfanstiehl

3 Prachin Chemical

2 Seppic

2 Shijiazhuang Huaxu Pharmaceutical

2 Finar

1 The Dow Chemical Company

1 Alcedo Pharmachem

1 Huzhou Sunflower Pharmaceutical Co. Ltd

1 Ideal Cures Pvt Ltd

1 Zhejiang Huakang Pharmaceutical

1 Jai Radhe Sales

1 Kima Chemical